Atsushi Osada

562 total citations
27 papers, 343 citations indexed

About

Atsushi Osada is a scholar working on Biomaterials, Molecular Biology and Oncology. According to data from OpenAlex, Atsushi Osada has authored 27 papers receiving a total of 343 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Biomaterials, 7 papers in Molecular Biology and 7 papers in Oncology. Recurrent topics in Atsushi Osada's work include Nanoparticle-Based Drug Delivery (6 papers), Sarcoma Diagnosis and Treatment (4 papers) and Immunotherapy and Immune Responses (4 papers). Atsushi Osada is often cited by papers focused on Nanoparticle-Based Drug Delivery (6 papers), Sarcoma Diagnosis and Treatment (4 papers) and Immunotherapy and Immune Responses (4 papers). Atsushi Osada collaborates with scholars based in Japan, United States and Serbia. Atsushi Osada's co-authors include Masutaka Furue, Kunihiko Tamaki, Katsuhiko Tsukamoto, Iulian Bobe, Juneko E. Grilley‐Olson, Hideki Nakashima, Reiko Kitamura, Lyudmila Bazhenova, Vivek Subbiah and Neelesh Sharma and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Cancer Research and Journal of Controlled Release.

In The Last Decade

Atsushi Osada

27 papers receiving 328 citations

Peers

Atsushi Osada
Atsushi Osada
Citations per year, relative to Atsushi Osada Atsushi Osada (= 1×) peers Toshiro Yano

Countries citing papers authored by Atsushi Osada

Since Specialization
Citations

This map shows the geographic impact of Atsushi Osada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Atsushi Osada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Atsushi Osada more than expected).

Fields of papers citing papers by Atsushi Osada

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Atsushi Osada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Atsushi Osada. The network helps show where Atsushi Osada may publish in the future.

Co-authorship network of co-authors of Atsushi Osada

This figure shows the co-authorship network connecting the top 25 collaborators of Atsushi Osada. A scholar is included among the top collaborators of Atsushi Osada based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Atsushi Osada. Atsushi Osada is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mpekris, Fotios, Myrofora Panagi, Christina Michael, et al.. (2022). Translational nanomedicine potentiates immunotherapy in sarcoma by normalizing the microenvironment. Journal of Controlled Release. 353. 956–964. 15 indexed citations
2.
Kato, Aki, et al.. (2022). A case of Nd:YAG laser-induced traumatic macular hole with good visual prognosis after vitrectomy with inverted internal limiting membrane technique. American Journal of Ophthalmology Case Reports. 25. 101391–101391. 2 indexed citations
3.
Mitsui, Hiroshi, et al.. (2022). Case of cutaneous myopericytoma in a child and a mini‐review of cases with children and adolescents. International Journal of Dermatology. 62(5). e307–e309. 1 indexed citations
4.
Riedel, Richard F., et al.. (2021). Results of NC-6300 (nanoparticle epirubicin) in an expansion cohort of patients with angiosarcoma.. Journal of Clinical Oncology. 39(15_suppl). 11543–11543. 2 indexed citations
5.
Chawla, Sant P., Sanjay Goel, Warren Chow, et al.. (2020). A Phase 1b Dose Escalation Trial of NC-6300 (Nanoparticle Epirubicin) in Patients with Advanced Solid Tumors or Advanced, Metastatic, or Unresectable Soft-tissue Sarcoma. Clinical Cancer Research. 26(16). 4225–4232. 29 indexed citations
6.
Volovăț, Simona Ruxandra, Tudor–Eliade Ciuleanu, P. Koralewski, et al.. (2020). A multicenter, single-arm, basket design, phase II study of NC-6004 plus gemcitabine in patients with advanced unresectable lung, biliary tract, or bladder cancer. Oncotarget. 11(33). 3105–3117. 20 indexed citations
7.
Subbiah, Vivek, Juneko E. Grilley‐Olson, Austin J. Combest, et al.. (2017). Phase Ib/II Trial of NC-6004 (Nanoparticle Cisplatin) Plus Gemcitabine in Patients with Advanced Solid Tumors. Clinical Cancer Research. 24(1). 43–51. 82 indexed citations
8.
Yamashita, Shunichi, Yuzo Kodama, Shoutaro Tsuji, et al.. (2016). TPC-144, a novel reversible LSD1 inhibitor, exhibited strong antitumor activity in preclinical models of AML and SCLC. European Journal of Cancer. 69. S86–S87. 2 indexed citations
9.
Sugenoya, Junichi, Masako Kato, Naoki Nishimura, et al.. (2005). Effects of body posture on local sweating and sudomotor outflow as estimated using sweat expulsion. Autonomic Neuroscience. 119(1). 48–55. 4 indexed citations
10.
Tsukamoto, Katsuhiko, et al.. (2002). Approaches to Repigmentation of Vitiligo Skin: New Treatment with Ultrasonic Abrasion, Seed‐Grafting and Psoralen Plus Ultraviolet A Therapy. Pigment Cell Research. 15(5). 331–334. 19 indexed citations
11.
Tsukamoto, Katsuhiko, Shuji Hirata, Atsushi Osada, Reiko Kitamura, & Shinji Shimada. (2000). Detection of Circulating Melanoma Cells by RT‐PCR Amplification of Three Different Melanocyte‐Specific mRNAs in a Mouse Model. Pigment Cell Research. 13(3). 185–189. 11 indexed citations
12.
Tsukamoto, Katsuhiko, Masato Ueda, Shuji Hirata, et al.. (2000). gp100 mRNA is more sensitive than tyrosinase mRNA for RT-PCR amplification to detect circulating melanoma cells in peripheral blood of melanoma patients. Journal of Dermatological Science. 23(2). 126–131. 12 indexed citations
13.
Osada, Atsushi, Hideki Nakashima, Masutaka Furue, & Kunihiko Tamaki. (1995). Up-Regulation of CD44 Expression by Tumor Necrosis Factor-α Is Neutralized by Interleukin-10 in Langerhans Cells. Journal of Investigative Dermatology. 105(1). 124–127. 33 indexed citations
14.
Osada, Atsushi, et al.. (1995). Expression of CD44 Antigen by Langerhans Cells and Thy1+ Dendritic Epidermal Cells - Ontogenetic Variation and Its Role in Migration. Advances in experimental medicine and biology. 378. 117–119. 1 indexed citations
15.
Furue, Masutaka, Atsushi Osada, Chung‐Hsing Chang, & Kunihiko Tamaki. (1994). Immunosuppressive Effects of Azelastine Hydrochloride on Contact Hypersensitivity and T-Cell Proliferative Response: A Comparative Study with FK-506. Journal of Investigative Dermatology. 103(1). 49–53. 9 indexed citations
16.
Tamaki, Kunihiko, Atsushi Osada, Katsuhiko Tsukamoto, Naoto OHTAKE, & Masutaka Furue. (1994). Treatment of plasma cell cheilitis with griseofulvin. Journal of the American Academy of Dermatology. 30(5). 789–790. 22 indexed citations
17.
Saitoh, Atsushi, Atsushi Osada, Yasuo Kitajima, Masutaka Furue, & Kunihiko Tamaki. (1994). Interferon‐γ‐induced HLA‐DR, but not ICAM‐1, Expression of Human Keratinocytes Is Down‐regulated by Calmodulin Antagonist. The Journal of Dermatology. 21(10). 716–719. 2 indexed citations
18.
Ogawa, Tokuo, et al.. (1993). Effects of body and head positions on bilateral difference in tympanic temperatures. European Journal of Applied Physiology. 67(4). 354–359. 17 indexed citations
19.
Saitoh, Atsushi, Atsushi Osada, Naoto OHTAKE, et al.. (1993). Erythrodermic bullous pemphigoid. Journal of the American Academy of Dermatology. 28(1). 124–125. 11 indexed citations
20.
Tanaka, Masahiro, Atsushi Osada, & Tetsuzo Tanino. (1991). Ellipsoidal Approximations in Set-Membership State Estimation of Linear Discrete-Time Systems. Transactions of the Society of Instrument and Control Engineers. 27(12). 1374–1381. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026